Lesokhin, A. M., Kaufman, J. L., Badros, A., Acosta, J., Müller, P., Lou, C., O'Connell, A., Afram, G., Suvannasankha, A. (2025). MagnetisMM-30: A phase 1b, open-label study of elranatamab in combination with iberdomide in patients with relapsed or refractory multiple myeloma (RRMM).. Journal of Clinical Oncology. https://doi.org/10.1200/jco.2025.43.16_suppl.tps7566